The global Insulin Lispro market is estimated to be valued at US$ 3.92 billion in 2022 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Insulin Lispro is a rapid-acting insulin analog that helps control blood sugar levels in people with diabetes. It is used for the treatment of both type 1 and type 2 diabetes. Insulin Lispro ... Read more
